A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(24 sites)

United States

Infirmary Health - Diagnostic & Medical Clinic (DMC), Mobile, Alabama

Chao Family Comprehensive Cancer Center UCI, Orange, California

University of Kansas, Westwood, Kansas

University of Maryland | Greenebaum Cancer Center, Baltimore, Maryland

Henry Ford Health System, Detroit, Michigan

Washington University School of Medicine, St Louis, Missouri

New York Oncology Hematology, Albany, New York

Australia

St George Private Hospital, Kogarah, New South Wales

Fiona Stanley Hospital, Murdoch, Western Australia

Austria

Universitaetsklinikum St. Poelten, Sankt Pölten

Krankenhaus der Barmherzigen Schwestern Wien, Vienna

Denmark

Odense Universitetshospital, Odense

Greece

Alexandra General Hospital of Athens, Athens

Hungary

Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvár

Italy

Azienda Ospedaliero-Universitaria delle Marche; SOD Clinica Medica, Torrette

Netherlands

Amsterdam University Medical Center (Amsterdam UMC), Amsterdam

St. Antonius Ziekenhuis, Nieuwegein

Poland

Aidport sp. z o.o., Skorzewo

Spain

Hospital Costa Del Sol, Marbella

Hospital Universitari Son Espases (HUSE) (Hospital Universitario Son Dureta) (HUSD), Palma de Mallorca

Hospital Universitari i Politecnic La Fe, Valencia

United Kingdom

Gloucestershire Royal Hospital, Gloucester, Gloucestershire

Cardiff & Vale University Health Board, Cardiff, South Glamorgan

County Hospital (Stafford Hospital), Stafford